A detailed history of Massmutual Trust CO Fsb transactions in Moderna, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 668 shares of MRNA stock, worth $24,909. This represents 0.0% of its overall portfolio holdings.

Number of Shares
668
Previous 793 15.76%
Holding current value
$24,909
Previous $94,000 53.19%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$63.64 - $125.14 $7,955 - $15,642
-125 Reduced 15.76%
668 $44,000
Q2 2024

Jul 02, 2024

BUY
$101.21 - $166.61 $22,468 - $36,987
222 Added 38.88%
793 $94,000
Q1 2024

Apr 09, 2024

BUY
$85.37 - $115.44 $20,232 - $27,359
237 Added 70.96%
571 $60,000
Q4 2023

Jan 03, 2024

SELL
$69.51 - $104.43 $11,747 - $17,648
-169 Reduced 33.6%
334 $33,000
Q3 2023

Oct 03, 2023

BUY
$96.41 - $126.61 $7,905 - $10,382
82 Added 19.48%
503 $51,000
Q2 2023

Aug 01, 2023

SELL
$118.5 - $160.53 $10,546 - $14,287
-89 Reduced 17.45%
421 $51,000
Q1 2023

Apr 11, 2023

BUY
$135.66 - $197.02 $45,581 - $66,198
336 Added 193.1%
510 $78,000
Q4 2022

Jan 06, 2023

BUY
$118.38 - $210.04 $4,853 - $8,611
41 Added 30.83%
174 $31,000
Q3 2022

Oct 07, 2022

BUY
$118.07 - $194.18 $3,424 - $5,631
29 Added 27.88%
133 $16,000
Q2 2022

Jul 07, 2022

BUY
$117.13 - $176.59 $4,568 - $6,887
39 Added 60.0%
104 $15,000
Q1 2022

Apr 08, 2022

BUY
$126.46 - $235.05 $4,299 - $7,991
34 Added 109.68%
65 $11,000
Q4 2021

Feb 09, 2022

SELL
$225.82 - $368.51 $24,840 - $40,536
-110 Reduced 78.01%
31 $8,000
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $31,287 - $68,310
141 New
141 $54,000
Q3 2020

Nov 13, 2020

SELL
$54.34 - $94.85 $7,607 - $13,279
-140 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $4,153 - $11,200
140 New
140 $9,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.